A case report of recovery of menstrual function following a nutritional intervention in two exercising women with amenorrhea of varying duration by unknown
Mallinson et al. Journal of the International Society of Sports Nutrition 2013, 10:34
http://www.jissn.com/content/10/1/34CASE REPORT Open AccessA case report of recovery of menstrual function
following a nutritional intervention in two
exercising women with amenorrhea of varying
duration
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Increasing caloric intake is a promising treatment for exercise-associated amenorrhea, but strategies have not been
fully explored. The purpose of this case report was to compare and contrast the responses of two exercising
women with amenorrhea of varying duration to an intervention of increased energy intake. Two exercising women
with amenorrhea of short (3 months) and long (11 months) duration were chosen to demonstrate the impact of
increased caloric intake on recovery of menstrual function and bone health. Repeated measures of dietary intake,
eating behavior, body weight, body composition, bone mineral density, resting energy expenditure, exercise
volume, serum metabolic hormones and markers of bone turnover, and daily urinary metabolites were obtained.
Participant 1 was 19 years old and had a body mass index (BMI) of 20.4 kg/m2 at baseline. She increased caloric
intake by 276 kcal/day (1,155 kJ/day, 13%), on average, during the intervention, and her body mass increased by
4.2 kg (8%). Participant 2 was 24 years old and had a BMI of 19.7 kg/m2. She increased caloric intake by 1,881 kcal/
day (7,870 kJ/day, 27%) and increased body mass by 2.8 kg (5%). Resting energy expenditure, triiodothyronine, and
leptin increased; whereas, ghrelin decreased in both women. Resumption of menses occurred 23 and 74 days into
the intervention for the women with short-term and long-term amenorrhea, respectively. The onset of ovulation
and regular cycles corresponded with changes in body weight. Recovery of menses coincided closely with
increases in caloric intake, weight gain, and improvements in the metabolic environment; however, the nature of
restoration of menstrual function differed between the women with short-term versus long-term amenorrhea.
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Exercising women frequently present with a chronic en-
ergy deficiency resulting from inadequate caloric intake to
compensate for energy expenditure [1,2]. In this popula-
tion, energy expenditure may be high due to the added en-
ergy cost of exercise. Therefore, when daily energy intake
does not match energy expenditure, there may be inad-
equate fuel to support all physiological processes [3]. As
a result, the physiological consequences of an energy
deficiency involve a cascade of metabolic and hormonal* Correspondence: mjd34@psu.edu
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reproduction in any medium, provided the oralterations that can suppress the reproductive axis and
cause menstrual disturbances such as functional hypo-
thalamic amenorrhea (FHA) and low bone mass [4,5].
The optimal treatment strategy for women with
exercise-associated amenorrhea and low bone mass is
to target the source of the problem, i.e., the energy defi-
ciency, by initiating a lifestyle intervention that includes
an increase in energy intake, and, if necessary, a de-
crease in exercise energy expenditure (EEE) [6]. Weight
gain often occurs secondary to such treatment and has
been observed to be a clinically positive outcome associ-
ated with resumption of menses and enhanced bone
health in exercising women [7-9].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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amenorrheic, exercising women who have increased cal-
oric intake and gained weight [7-10]. Dueck et al. [10]
and Kopp-Woodroffe et al. [8] described a case study of
five amenorrheic athletes who increased caloric intake
for 12 to 20 weeks, resulting in weight gain of 1 to 3 kg
and the resumption of menses in 3 of 5 participants dur-
ing the intervention. Fredericson and Kent [7] reported
a case study of an amenorrheic athlete who gained
weight over the course of 5 years, resulting in the main-
tenance of normal menstrual cycles and improved bone
health. Similarly, Zanker et al. [9] followed an amenor-
rheic athlete for 12 years and reported increases in bone
mineral density (BMD) of the proximal femur with in-
creases in body mass index (BMI). There are, however,
no case studies published to date that document the
simultaneous changes in energetic and metabolic status
and the associated effects on hormonal attributes of re-
productive recovery and bone health in amenorrheic ex-
ercising women. Indeed, the case studies reported to
date have limited their findings solely to the outcome of
recovery of menses rather than the documentation of
the hormonal aspects of menstrual recovery that include
estrogen exposure, progesterone exposure, and ovulation
over the course of 12 months of increasing calorie in-
take. The absence of detailed reports describing the
metabolic and hormonal environment surrounding re-
sumption of menses in exercising women with FHA has
resulted in a lack of evidence on which to base effective
dietary treatment strategies. As such, the value of this
case report lies in the opportunity to study the manifest-
ation and resolution of this complex problem using de-
tailed hormonal analyses in an effort to gain a better
understanding about the interplay of factors that may
contribute to the induction and reversal of FHA in exer-
cising women.
Therefore, the purpose of this case report was to com-
pare and contrast the recovery of two exercising women
with current FHA of varying duration (short-term vs.
long-term) to a 12-month nutritional intervention. Thus,
this case report will describe, in detail, the changes in
energetic status, and the hormonal aspects of recovery




For the purpose of this case report, two exercising
amenorrheic women (aged 19–24 years) with current
amenorrhea of short (3 months) and long (11 months)
duration were chosen to demonstrate the impact of in-
creased caloric intake on the hormonal aspects of recov-
ery of menstrual function and bone health. The two
individuals were chosen because they both demonstratedgood compliance to an intervention of 12 months of in-
creased caloric intake targeted to exceed baseline total
energy expenditure (TEE) needs by 20-30%, and the on-
going nature of the intervention precludes inclusion of
the entire sample of women that participated in the
intervention. Both women successfully resumed menses.
The presence of amenorrhea at the beginning of the
intervention was confirmed by the analysis of daily
urinary excretion of estrone-1-glucuronide (E1G) and
pregnanediol glucuronide (PdG) metabolites for one 28-
day monitoring period. Both women were recreationally
active, engaging in > 7 hours of exercise per week at
baseline. The primary outcome variables in the 12-
month intervention were indices of energy status, bone
health and menstrual status.
Inclusion criteria
The two women in this case report were exercising
women who met the following inclusion criteria: 1) age
18–35 years, 2) BMI 16–25 kg/m2 [11], 3) weight stable
(± 2 kg) for the past 6 months, 4) no history of any ser-
ious medical conditions, 5) no current clinical diagnosis
of an eating or psychiatric disorder, 6) non-smoking,
7) no medication use that would alter metabolic or re-
productive hormone concentrations, 8) ≥ 3 hrs/wk aer-
obic exercise, 9) no menses for the past 3 months, and
10) no history of a clinical diagnosis of polycystic ovar-
ian syndrome (PCOS), or a free androgen index (FAI),
calculated as (total testosterone (nmol/L)/sex hormone
binding globulin (SHBG) (nmol/L))*100), > 6 [12]. In
addition, the women in this case report presented with
current amenorrhea of varying duration, i.e., short-term
amenorrhea defined as the cessation of menses for
<100 days and long-term amenorrhea defined as the ab-
sence of menses for >100 days [13].
Screening procedures
Participants signed an informed consent approved by
the Institutional Review Board at the University of
Toronto or Pennsylvania State University. Height and
weight were measured, and participants completed ques-
tionnaires to assess medical history, exercise and men-
strual history, eating behaviors, and psychological health.
A physical exam and blood sample was performed to de-
termine overall health. A semi-structured psychological
interview was conducted to ensure that the women were
not experiencing major psychiatric disorders, and a reg-
istered dietitian assessed eating patterns and food prefer-
ences. Dual-energy x-ray absorptiometry (DXA) scans
were performed to assess BMD and body composition.
Baseline procedures
During a 4-week baseline period, menstrual calendars
and daily urine samples for the assessment of menstrual
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weekly. At week 3 of baseline, energetic markers (leptin,
ghrelin, total triiodothyronine (TT3)), markers of bone
formation and resorption, body composition, resting en-
ergy expenditure (REE), and dietary intake were assessed.
Participants also completed a test of aerobic fitness.
Classification of baseline menstrual status
Upon study entry, classification of menstrual status was
based on self-reported menstrual history, which was
confirmed by a 28-day urinary profile of E1G, PdG, and
luteinizing hormone (LH) profiles during a 4-week base-
line period. FHA was assessed by confirming a negative
pregnancy test, normal endocrine panel, no menses in
the past 90 days, and documentation of chronically
suppressed E1G and PdG profiles observed during the
baseline period.
Intervention procedures for energy calculations
Both participants were asked to increase their caloric in-
take 20-30% above baseline TEE while maintaining their
usual exercise training regimen. For the purpose of this
report, baseline TEE was operationally defined as the
sum of REE and purposeful EEE. Energy bars that
contained approximately 250–300 kilocalories (1,046-
1,255 kJ) were provided by the research staff to increase
caloric intake. The target increase in caloric intake was
gradually achieved by a slow increase in calories during
the first several weeks of the intervention to encourage
compliance. A registered dietitian met with the partici-
pants regularly to provide strategies to meet the target
caloric intake. Participants also regularly met with a clin-
ical psychologist or licensed clinical social worker to
monitor general psychological health.
Assessment of menstrual function during the intervention
Menstrual function was monitored daily during the
intervention by assessing urinary excretion of E1G, PdG,
and LH metabolites and the presence of menses as self-
reported on monthly calendars. The methods used for
the assessment and categorization of menstrual cycles
are detailed and have previously been published [2].
Recovery of menstrual function categories
To describe the recovery of menstrual function, we clas-
sified recovery using several definitions of recovery that
ranged in hormonal and clinical relevance. Recovery
Category 1 was described simply as “recovery of men-
ses.” The successful recovery of menses after the base-
line period was defined as the first occurrence of
menstrual bleeding during the intervention. For further
analysis of the recovery of menstrual function, Recovery
Category 2 was described as resumption of menses pre-
ceded by ovulation based on increases in urinary E1G(above 35 ng/ml), PdG (above 2.5 μg/ml), and mid-cycle
LH (above 25 mIU/ml) concentrations [2,14]. Recovery
Category 3 was described as resumption of menses
followed by at least 2 menstrual cycles of less than
36 days each.
Anthropometrics
Total body weight was measured by a digital scale dur-
ing each week of the baseline period and every two
weeks during the intervention. Height was measured
during the screening period, and BMI was calculated as
a ratio of weight to height (kg/m2). Baseline values for
body weight and BMI were reported as the average of all
baseline and screening measurements.
Eating behavior assessment
Participants completed the Three Factor Eating Ques-
tionnaire (TFEQ) and Eating Disorder Inventory-2
(EDI-2) at screening and at months 2, 3, 6, 9, and 13
(post-study) to assess eating behavior. The TFEQ is a
51-item questionnaire with three subscales – cognitive
dietary restraint (CDR), disinhibition, and hunger. Cog-
nitive dietary restraint was evaluated according to the
following ranges established by Stunkard and Messick
[15]: 0–10 indicated low CDR, 11–13 indicated high
CDR, and 14–21 indicated the clinical range. The EDI-2
is a 91-item questionnaire with 8 subscales and 3
provisional subscales, as previously reported [16]. Scores
on the first 8 subscales were compared to published
means and 95% confidence intervals of eating disorder
patients and non-patient college females to assess for
symptoms of disordered eating and associated psycho-
logical features [17].
Body composition and bone mineral density
DXA scans of the total body, lumbar spine, and dual
femur were performed to assess body composition and
BMD. Body composition was measured at screening and
baseline and during months 1, 2, 3, 6, 9, and 13 (post-
study). BMD was assessed at all three sites at screening,
month 6, and month 13 (post-study). The participants
were scanned on either a GE Lunar Prodigy or Lunar
iDXA (GE Lunar Corporation, Madison, WI). Consistent
with the International Society of Clinical Densitometry
guidelines, a cross calibration study was performed to
remove systematic bias between the systems as previ-
ously published [18].
Dietary energy intake
Dietary energy intake was assessed from 3-day diet logs
(2 weekdays and 1 weekend-day) completed during week
3 of baseline and each month during the intervention as
previously published [18]. Participants met with a regis-
tered dietitian regularly who trained them how to record
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ergy intake logs. Participants received written guidelines
regarding proper measurement and reporting of food
portions and preparation.
Resting energy expenditure
REE was determined by indirect calorimetry during week
3 of baseline and months 2, 3, 6, 9, and 13 (post-study)
(Sensormedics Vmax metabolic cart, Yorba Linda, CA).
Methods explaining the measurement of REE have been
published in detail elsewhere [18]. Predicted REE (pREE)
was also calculated using the Harris Benedict equation
[19]. We compared the lab-assessed REE to the pre-
dicted REE (REE/pREE) to estimate how much the mea-
sured REE deviated from the predicted REE. A reduced
ratio of measured REE to Harris-Benedict predicted REE
of 0.60-0.80 has been reported during periods of low
body weight and prior to refeeding in anorexic women
[20-22]. We have previously published data using a ratio
of REE/pREE <0.90 as the operational definition of an
energy deficiency [1,4,16,23]. As such, in this study, a ra-
tio <0.90 was used to discriminate between being energy
deficient and energy replete.
Purposeful exercise energy expenditure
Purposeful EEE was estimated at baseline and monthly
during the intervention using a Polar heart rate moni-
tor. Participants completed exercise logs where all pur-
poseful exercise sessions greater than 10 minutes in
duration were recorded for a 7-day period. Energy
expended during these purposeful exercise sessions was
measured using the OwnCal feature of the Polar S610
or RS400 heart rate monitors (Polar Electro Oy,
Kempele, Finland) [24]. The OwnCal feature has been
validated for the use in calculating EEE from heart rate.
The Polar S601 and RS400 hear rate monitors include
rest in their estimation of energy expenditure. To esti-
mate only EEE, we subtracted the most recently mea-
sured REE (kcal/min) from the Polar heart rate
monitors’ estimation of energy expenditure. For pur-
poseful exercise sessions in which participants did not
wear the Polar S610 or RS400 heart rate monitors, the
Ainsworth et al. [25,26] compendiums of physical activ-
ities were used to determine the appropriate metabolic
equivalent (MET) level for the exercise performed [27].
To calculate the energy expended during the exercise
session, the MET level was multiplied by the duration
(min) of the exercise session and the measured REE
(kcal/min). The MET value includes a resting compo-
nent. To estimate only EEE, we subtracted the most re-
cently measured REE (kcal/min) from this value.
Participants also recorded the type and duration of
purposeful physical activity using daily exercise logs to
provide a measure of exercise volume during the study.Exercise testing
Maximal aerobic capacity (VO2max) was measured dur-
ing a progressive treadmill test to volitional exhaustion
using an on-line MedGraphics Modular VO2 System (St
Paul, MN) or SensorMedics Vmax metabolic cart (Yorba
Linda, Calif., USA) during week 3 of baseline using
methods previously published [28].
Urinary reproductive hormone measurements
To determine estrogen and progesterone exposure, E1G
and PdG urinary metabolites were assessed using a
modified trapezoidal integrated area under the curve
(AUC) technique. To calculate AUC, the hormone con-
centrations for two consecutive days of the cycle were
averaged; these averages were then summed to provide
AUC for the cycle. The methods for measuring urinary
reproductive hormones have been previously published
[2]. The inter-assay coefficients of variation for high
and low internal controls for the E1G assay are 12.2%
and 14.0%, respectively. The PdG intra- and inter-assay
variability was determined in-house as 13.6% and 18.7%,
respectively [2,14]. Urinary LH was determined by coat-
a-count immunoradiometric assay (Siemens Healthcare
Diagnostics, Deerfield, IL). The sensitivity of the LH
assay is 0.15 mIU/ml. The intra- and inter-assay coeffi-
cients of variation were 1.6% and 7.1%, respectively.
Blood sampling
Blood was collected, processed, and stored after an over-
night fast between 0700 and 1000 once during week 3 of
baseline and once at the end of baseline using methods
previously published in detail [18]. The latter two sam-
ples were pooled for all baseline hormone analyses. In
addition, blood samples were collected during months 2,
3, 4, 5, 6, 9, 13 (post-study).
Serum hormone analysis
The metabolic hormones TT3, leptin, and ghrelin were
measured using previously published methods [18,29].
Bone markers including pro-collagen type 1 amino-
terminal propeptide (P1NP) and collagen type 1 cross-
linked C-telopeptide (CTx) were also measured. P1NP
was analyzed by radioimmunoassay (RIA) (Immunodiag-
nostic Systems, Inc., Scottsdale, AZ). The sensitivity of
the assay was 2 μg/L. Intra-assay and inter-assay coeffi-
cients of variation were between 6.5-10.2% and 6.0-9.8%,
respectively. CTx was analyzed by enzyme-linked im-
munosorbent assay (ELISA) (Immunodiagnostic Sys-
tems, Inc., Scottsdale, AZ). The sensitivity of the assay
was 0.02 ng/mL. Intra-assay and inter-assay coefficients
of variation for the low control were 3.0 and 10.9%, re-
spectively. All samples from a given participant were
analyzed in duplicate.
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Participant 1: long-term amenorrhea
Characteristics at baseline
This participant was a 19-year old recreationally active
college student who participated in a wide variety of ac-
tivities such as running, weightlifting, rock climbing,
hiking, and downhill skiing. At baseline, she reported
12 hours of physical activity each week and averaged
about 9 hr/wk of purposeful EEE during the study. Des-
pite presenting with a normal BMI of 20.4 kg/m2 and
body fat of 20.6%, she had been amenorrheic for
11 months when the intervention commenced and urin-
ary analysis of E1G and PdG confirmed suppressed ovar-
ian activity (Table 1, Figure 1). She presented with a
dietary CDR score of 12 which is elevated but not above
the clinical threshold of 14 [15]. Scores on the subscales
of the EDI-2 were within or below the normal range for
college-aged women and did not indicate disordered eat-
ing (Table 2). The baseline semi-structured psychological
interview revealed that the participant felt good about
herself and her healthy eating pattern. There was no evi-
dence of current or past eating disorders. Over the
course of the study, Participant 1 reported having no dif-
ficulty following the energy intake prescriptions.
Changes in energetic status
The participant was instructed to gradually increase her
daily dietary intake by 500 kcal/day (2,092 kJ/day) which
represented an increase of 31% above her baseline en-
ergy requirement (TEE) and a target caloric intake forTable 1 Baseline descriptives of the women
Participant 1 Participant 2
Demographic characteristics
Age (yr) 19 24
Height (cm) 164.0 165.5
Weight (kg) 54.7 54.0
BMI (kg/m2) 20.4 19.7
Body fat (%) 20.6 22.7
Reproductive characteristics
Age of Menarche (yr) 15 13
Gynecological age (yr) 4 9
Duration of amenorrhea (days) 330 90
Duration until resumption 74 23
(days in intervention)
# Cycles during intervention 6 9
Training characteristics
Physical activity (min/wk)* 761 438
VO2max (ml/kg/min) 50.1 43.5
*Self-reported exercise during baseline.
BMI: body mass index; VO2max: maximal oxygen consumption.the intervention of 2,600 kcal/day (10,878 kJ/day). The
participant’s caloric intake was 2,143 kcal/day (8,966 kJ/
day) at baseline and increased to an average intake of
2,419 kcal/day (10,121 kJ/day) during the intervention. Ex-
ercise volume remained relatively constant throughout the
intervention, ranging from 7 to 12 hr/wk. Weekly EEE av-
eraged 685 kcal/day (2,866 kJ/day) with a range of 319 to
1,013 kcal/day (1, 335 – 4,238 kJ/day).
During the intervention, the participant demonstrated
a progressive weight gain of 1.8 kg at month 3, 2.1 kg at
month 6, and 4.2 kg after month 12 of the intervention
when compared to her baseline weight. The increase in
weight coincided with an increase in BMI from 20.4 kg/
m2 at baseline to 22.0 kg/m2 after month 12. Fat and
lean mass (LBM) increased by 11.7% and 8.3%, respect-
ively, which translated to an increase of 1.3 kg of fat
mass and 3.4 kg of lean mass. Percent body fat increased
from 20.6% to 21.1%. The greatest increase in fat mass
was observed at month 9 with an increase of 2.0 kg from
baseline, and a concomitant increase in circulating leptin
concentration of 105.7% from baseline to month 9. An
increase in REE from 27.20 to 32.61 kcal/day/kg LBM
(113.8 to 136.4 kJ/day/kg LBM) was observed from base-
line to month 12. The REE/pREE ratio also increased
from 0.81 at baseline to 1.01 at the end of the study,
demonstrating an improvement in energy status. Further
evidence of an improved energy state is corroborated by
a 39.4% increase in TT3 and a 59.2% decrease in ghrelin
concentrations (Table 3).
Changes in menstrual status
After 2.5 months (74 days) in the intervention, menses
resumed (Figure 1). However, due to the anovulatory na-
ture of the cycle preceding resumption, estrogen expos-
ure, as assessed by E1G AUC, was not improved from
the baseline period to the time period preceding re-
sumption. For the first two months after resumption,
two consistently eumenorrheic but anovulatory cycles of
28 to 33 days in length were observed (Figure 1). About
6 months into the intervention, however, she experi-
enced another brief episode of amenorrhea with 92 days
elapsing between menses. About 8 months in the inter-
vention and 3 months after her last menses (92 days),
she resumed menses for a second time. A long inter-
menstrual interval of 68 days characterized the first cycle
after resumption. During this time, a decrease in caloric
intake of approximately 400 kcal/day (1,674 kJ/day) in
the face of a consistent volume of EEE was observed.
The participant was informed of the decrease in caloric
intake and was instructed again to increase her daily en-
ergy intake to 2,600 kcal/day (10,878 kJ/day). She was
moderately successful, increasing her intake to approxi-
mately 2,350 kcal/day (9,832 kJ/day). Consequently, the
cycle following the second resumption was ovulatory but
Figure 1 Reproductive hormone profile for Participant 1. This figure displays the reproductive hormone profile during the study for
Participant 1 and the changes in caloric intake, body weight, and energy status that coincided with each category of menstrual recovery. Arrows
indicate menses. Body weight was measured within 1 week of menses. ‡ Indicates data were collected 2 weeks before menses. † Indicates data
were collected 6 weeks after menses. %BF: percent body fat; BMI: body mass index; BW: body weight; E1G: estrone-1-glucuronide; PdG:
pregnanediol glucuronide; REE/pREE: measured resting energy expenditure/predicted resting energy expenditure; TT3: total triiodothyronine.
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the first ovulatory cycle that this participant experienced
during the intervention. Estrogen exposure during the
28 days preceding the ovulation-associated menses in-
creased 64.3% compared to the baseline cycle. Further-
more, despite its anovulatory nature, the length of the
subsequent and final cycle during the study declined
sharply with an intermenstrual interval of 21 days.Changes in bone health
As Table 4 demonstrates, the participant had a low
BMD at the lumbar spine at baseline. After the 12-
month intervention, no increases in BMD were observed
at any skeletal site; however, P1NP, a marker of bone for-
mation, increased by 49.6%.Participant 2: short-term amenorrhea
Characteristics at baseline
This participant was a 24-year old graduate student who
participated in approximately 7 hours of exercise each
week, consisting of dancing, running, and weight train-
ing. She presented with a normal BMI of 19.7 kg/m2 and
percent body fat of 22.7%; however, at the start of the
intervention, she had not had menses for three months,
and her menstrual history revealed multiple extended
episodes of amenorrhea (Table 1). Menarche occurred at
13 years of age. At age 16, she experienced an 8-month
episode of amenorrhea. After she resumed menses, she
had regular cycles until the age of 21 years when she ex-
perienced a prolonged episode of amenorrhea for
2.5 years that she associated with low food intake, stress,
and excessive exercise. During this time of amenorrhea,
Table 2 Baseline, month 6, and post-intervention scores
on subscales of the Three Factor Eating Questionnaire
and Eating Disorder Inventory-2
Eating behavior scores Participant 1 Participant 2
Cognitive dietary restraint
Baseline 12 12












Month 6 5 13
Post-Intervention 6 12
Table 4 Baseline measurements and the 6-month and
12-month percent change for bone marker
concentrations and BMD
Participant 1 Participant 2
Bone markers
P1NP (μg/L) 52.90 36.95
6 month % change 5.6 22.6
12 month % change 49.6 51.6
CTx (ng/ml) 0.65 0.64
6 month % change −23.1 −29.0
12 month % change 17.7 −36.1
Bone mineral density
Lumbar spine Z-score −1.6 −1.4
Lumbar spine BMD (g/cm2) 0.983 1.056
6 month % change 1.7 2.6
12 month % change 0.8 2.0
Femoral neck Z-score 0.5* −0.6
Femoral neck BMD (g/cm2) 1.062 0.994
6 month % change −2.8 −0.3
12 month % change −4.3 1.4
Hip Z-score 0.0* −1.1
Hip BMD (g/cm2) 0.996 0.955
6 month % change −1.3 −0.4
12 month % change −2.0 1.9
*Z-score at month 6.
BMD: bone mineral density; CTx: collagen type 1 cross-linked C-telopeptide;
P1NP: pro-collagen type 1 amino-terminal propeptide.
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to the weight of 53.8 kg which was measured at the
baseline period of this report. Ten months prior to
starting this study, she resumed sporadic menses,
reporting 5 cycles during those months. Menstrual dis-
turbances were still present, however, as confirmed by
self-reported long cycles and suppressed concentrations
of E1G and PdG measured at baseline.
The participant presented with an elevated but not
clinical dietary cognitive restraint score of 12 and scores
that were above normal for college-aged women and
within the range for eating disorder patients for theTable 3 Baseline measurements and the 6-month and
12-month percent change for metabolic hormone
concentrations
Participant 1 Participant 2
Metabolic hormones
Leptin (μg/ml) 5.1 2.4
6 month % change −19.8 230.9
12 month % change −17.3 279.8
Total Ghrelin (pmol/L) 534.8 490.3
6 month % change −35.9 −15.2
12 month % change −59.2 −12.1
Total Triiodothyronine (nmol/L) 0.82 1.06
6 month % change 8.0 6.3
12 month % change 39.4 31.5
Ghrelin conversion: pg/ml x 0.296 = pmol/L.
Triiodothyronine conversion: ng/dl x 0.0154 = nmol/L.following four subscales of the EDI-2: ineffectiveness,
perfectionism, interpersonal distrust, and interoceptive
awareness [17] (Table 2). The baseline semi-structured
psychological interview revealed that Participant 2 had a
history of clinical diagnosis of anorexia nervosa and al-
though she no longer met criteria for a clinical eating
disorder, she continued to have associated characteristics
such as perfectionism, social anxiety and reservations
about trusting others.
Changes in energy status
The participant was instructed to gradually increase
daily dietary intake by 400 kcal/day (1,674 kJ/day),
representing an increase of 27% above her baseline en-
ergy requirements (TEE) and a target caloric intake of
1,900 kcal/day (7,950 kJ/day). Her caloric intake in-
creased from 1,482 kcal/day (6,201 kJ/day) at baseline to
an average intake of 1,917 kcal/day (8,021 kJ/day) for the
first six months of the study. During the latter 6 months,
an average intake of 1,838 kcal/day (7,690 kJ/day) was
observed. Exercise volume ranged from 3 to 7 hr/wk
during the intervention with the exception of one month
during which 10 hours of purposeful EEE were reported.
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range of 30 to 508 kcal/day (126–2,125 kJ/day).
The participant gradually gained weight for the first
6 months of the intervention such that by month 6, her
weight had increased by 2.4 kg. After 12 months, the
total weight gain was 2.8 kg, indicating that her weight
remained relatively stable during the last 6 months of
the study. Coinciding with this increase in weight, BMI
increased from 19.7 kg/m2 to 20.7 kg/m2, and fat mass
steadily increased with a total gain of 2.2 kg (17.5% in-
crease). Interestingly, lean mass decreased 1.4 kg (−3.3%)
after 12 months which primarily occurred during the last
6 months of the study. Leptin concentrations increased
during the study (279.8% increase) (Table 3). Improve-
ment in energy status was demonstrated by an increase
in REE from 28.1 kcal/day/kg LBM (117.6 kJ/day/kg
LBM) to 32.8 kcal/day/kg LBM (137.2 kJ/day/kg LBM)Figure 2 Reproductive hormone profile for Participant 2. This figure d
Participant 2 and the changes in caloric intake, body weight, and energy st
indicate menses. ‡ Indicates data were collected 5 weeks after menses. † In
fat; BMI: body mass index; BW: body weight; E1G: estrone-1-glucuronide; nr
resting energy expenditure/predicted resting energy expenditure; TT3: totaat the completion of the study which coincided with an
increase in the REE/pREE ratio from 0.87 to 0.94. Fur-
ther evidence for this improved energy state was an in-
crease in TT3 (31.2%) and a decrease in ghrelin
(−12.1%) (Table 3).
Changes in menstrual status
The participant resumed menses 23 days after the start of
the intervention, an event that was preceded by ovulation
(Figure 2). Estrogen exposure increased 139.4% from base-
line to the cycle preceding the resumption of menses. How-
ever, menses was not reported for the following 4 months
and chronically suppressed concentrations of E1G and PdG
were observed, confirming the presence of another episode
of amenorrhea. During this period of amenorrhea, body
weight and caloric intake decreased slightly toward baseline
values then increased again, leading to a second resumptionisplays the reproductive hormone profile during the study for
atus that coincided with each category of menstrual recovery. Arrows
dicates data were collected 3 days after menses. %BF: percent body
: not reported; PdG: pregnanediol glucuronide; REE/pREE: measured
l triiodothyronine.
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the remaining 7 months of the study, 8 more cycles were
reported, with consistent cycle lengths of 24 to 29 days
(Figure 2). Despite consistent intermenstrual intervals, the
cycles were characterized by subtle menstrual disturbances.
Of the 10 cycles reported during the study, 6 were ovula-
tory and 4 were anovulatory. Of the ovulatory cycles, all of
them displayed a luteal phase defect. Four cycles were char-
acterized by both a short and inadequate luteal phase, one
cycle had just a short luteal phase, and one cycle had an in-
adequate luteal phase.
Changes in bone health
As depicted in Table 4, low BMD at the lumbar spine and
hip were observed at baseline. No significant increases in
BMD were observed; however, P1NP increased by 51.6%
and CTx decreased 36.1%, demonstrating a favorable
change in bone turnover.
Discussion
This case report examined the effects of a 12-month
controlled intervention of increased caloric intake in two
exercising women with current amenorrhea of varying
duration and documents for the first time the simultan-
eous response of markers of energetic status, daily
changes in reproductive hormones, and markers of bone
health. The two women in this case report successfully
gained weight and resumed menses in response to the
non-pharmacological intervention of increased caloric
intake. We also document the onset of ovulatory func-
tion and regular inter-menstrual intervals in these
women and highlight the improved energetic milieu that
preceded the reproductive milestones.
Resumption of menses successfully occurred in both
women with an intervention that increased caloric intake
rather than decreased EEE, a strategy that may be attract-
ive to both athletes and coaches because it does not inter-
fere with training volume or intensity. The increase in
caloric intake was tailored to the individualized energy re-
quirements of each participant and was associated with an
increase in body weight and an improved energy status.
On average, an increase in body weight of 3.5 kg was ob-
served commensurate with an increase in REE from base-
line to the completion of the study. In our lab, we have
used the ratio of REE/pREE as an indicator of energy sta-
tus and have operationally defined an energy deficiency as
a ratio <0.90 [4,16,23]. Both women presented with a ratio
<0.90 at baseline, indicative of an energy deficient state.
Previous reports of the REE/pREE ratio in amenorrheic
exercising women have ranged from 0.80 to 0.95 [4,28,30]
and in anorexic women from 0.60 to 0.80 [20-22]. The
two women in this case report resumed menses and expe-
rienced increases in REE such that the REE/pREE ratio
improved to above 0.90 at the completion of theintervention, indicative of an improvement in energy sta-
tus and reversal of the energy deficiency.
Likewise, changes in TT3 and ghrelin concentrations
paralleled the changes in body weight and REE and pro-
vide support for the critical importance of an energy re-
plete state for the successful resumption of menses.
Interestingly, fasting concentrations of TT3 increased
and ghrelin decreased during the intervention in both
women. TT3 is a well-known marker of energy status
and is often suppressed among amenorrheic athletes
when compared to their ovulating counterparts and sed-
entary women [1,28]. In fact, it has been shown in the
non-human primate model that induction of amenor-
rhea via an increase in exercise volume and caloric ex-
penditure results in a significant decrease in circulating
concentrations of TT3 that is reversed with increases in
caloric intake and resumption of menses [31]. Ghrelin,
on the other hand, is an orexigenic hormone that regu-
lates appetite and is commonly elevated among amenor-
rheic exercising women [28,32]. Therefore, an increase
in fasting concentrations of TT3 and a decrease in ghrelin
provide evidence for improvements in energy status.
In response to the intervention, each woman success-
fully resumed menses as defined by the occurrence of
menstrual bleeding and experienced at least one cycle
that was preceded by ovulation. However, in association
with varying duration of amenorrhea, the changes ob-
served for each woman in dietary intake, body weight,
and the energetic environment that were associated with
the reproductive milestones varied. For Participant 1
with long-term amenorrhea, it appeared that weight gain
greater than 2 kg coincided with recovery of menses and
a gain of about 3 kg coincided with ovulation. However,
for Participant 2 with short-term amenorrhea, minimal
change in weight prior to the first menses during the
study was observed, but approximately 2 kg of weight
gain was necessary before the onset of regular cycles. It
should be noted, however, that upon entrance into the
study Participant 2 reported experiencing long inter-
menstrual intervals in the previous year, indicative of an
oligomenorrheic profile. Thus, it appears that upon
commencement of the intervention, this woman was
presumably in the early stages of recovery, and the first
menses observed during the study may have been an-
other sporadic menses similar to those that she had been
experiencing for the past 10 months. Robust increases in
caloric intake and subsequent weight gain may have
aided resumption of regular intermenstrual intervals as
evidenced by consistent cycles of 24 to 29 days in length
for the last 7 months of the study.
Body composition and the metabolic milieu at baseline
may have played a role in both the time to and quality
of recovery of menses. At baseline, both women
presented with a BMI and percent body fat within the
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2 (short-term amenorrhea) presented with a greater per-
cent body fat at baseline than Participant 1. Body fat has
been recognized as playing an important permissive role
in reproductive function through the effects of leptin,
an adipocyte-derived metabolic hormone [33,34]. Leptin
binds to receptors in the hypothalamus, stimulating the
release of gonadotropin-releasing hormone [35,36] and
thereby playing a regulatory role in reproductive func-
tion via its influence on gonadotropin pulsatility and re-
productive steroid production [37]. Alterations in leptin
secretion parallel changes in fat mass; however, leptin se-
cretion is also sensitive to acute alterations in circulating
concentrations of glucose [38] and insulin [39]. Conse-
quently, a change in leptin concentration may occur
prior to a change in fat mass [37]. In this way, leptin
may be mediating recovery of menstrual function prior
to notable changes in fat mass. In this case report, Par-
ticipant 2 with short-term amenorrhea demonstrated ro-
bust increases in fat mass and leptin concentration
within the first 6 months of the intervention and, coin-
ciding with this increase in leptin, displayed both an
ovulatory cycle and resumption of regular cycles early in
the intervention. On the other hand, Participant 1 with
long-term amenorrhea gained minimal fat mass and
showed no increase in leptin concentration during the
first 6 months of the intervention despite an increase in
circulating TT3. Interestingly, she did not experience an
ovulatory cycle until month 11 after demonstrating a
gain in fat mass of 2.0 kg and increase in leptin concen-
tration of 106% at month 9 of the intervention. Of fur-
ther interest is that body fat and leptin concentration
decreased again by month 12; whereas, REE and TT3
concentration continued to increase during the last few
months of the intervention. Therefore, the woman with
short-term amenorrhea seemed to recover faster second-
ary to robust increases in fat mass and leptin early in the
intervention; whereas, the woman with long-term amen-
orrhea required more time to achieve an ovulatory cycle
and demonstrated cycles of greater inconsistency, coin-
ciding with inconsistent changes in fat mass and circu-
lating leptin concentration. As such, in agreement with
other investigators [34], leptin concentration, which is
strongly correlated with percent body fat [18], likely
plays a role in recovery of menses. Furthermore, the
woman with long-term amenorrhea (Participant 1)
maintained a lower percent body fat as well as greater
exercise volume throughout the intervention compared
to the woman with short-term amenorrhea (Participant
2), providing further potential reasons for the differ-
ences observed during recovery of menstrual function.
Of interest, however, is that neither woman experi-
enced complete recovery of menstrual function as de-
fined by the occurrence of consistent ovulation andregular cycles of 26 to 35 days during the course of the
intervention. Despite the onset of menses, subtle men-
strual disturbances or long intermenstrual intervals were
observed throughout the study. The presence of subtle
menstrual disturbances in exercising women who are
regularly cycling is not uncommon [2,14]. In fact, it has
been reported that about 52% of exercising women ex-
perience subtle menstrual disturbances in the face of ap-
parently regular cycles [2]. Thus, it is plausible that
women who are recovering from amenorrhea may also
experience these subtle menstrual disturbances prior to
complete recovery of optimal menstrual function which
may require more time than 12 months.
Furthermore, it is notable that both women experienced
a decrease in energy intake during the intervention that
corresponded with long intermenstrual intervals consist-
ent with the definition of amenorrhea and oligome-
norrhea. This non-compliance with the prescribed energy
intake, whether inadvertent or intentional, for a period of
time during the intervention may have also contributed to
the time course of recovery of menstrual function and the
lack of complete recovery of optimal menstrual function.
However, both women increased caloric intake again after
this period of non-compliance, coinciding with ovulation
and the onset of regular cycles for Participant 1 and 2, re-
spectively. These events further demonstrate the import-
ance of adequate energy intake on menstrual function
among exercising women.
No improvements in bone health for either woman were
observed, likely secondary to the relatively short interven-
tion of 12 months. For bone health outcomes, a longer
intervention of 18 to 24 months may be required to realize
significant changes in bone density and strength. Neither
woman demonstrated a clinically significant increase in
BMD as defined by a change that exceeded the least sig-
nificant change; however, P1NP, a marker of bone forma-
tion, increased by approximately 50% in both women. This
favorable change in bone turnover may indicate that more
significant BMD changes may have been observed if the
participants were followed for a longer duration of time.
Other case studies of amenorrheic athletes who gained
weight demonstrated significant improvements in bone
health [7,9]. Frederickson et al. [7] reported a 25.5% and
19.5% increase in lumbar spine and hip BMD, respect-
ively, over 8 years after a gradual weight gain of 17 kg in
an athlete who presented with amenorrhea and very low
BMD. Similarly, Zanker et al. [9] observed a 16.9% in-
crease in hip BMD after weight gain of 8 kg over
36 months in an endurance athlete with primary amen-
orrhea and low BMD. These case studies demonstrate
that weight gain can lead to significant increases in
BMD if an adequate energy state is achieved and ad-
equate time has passed to allow for measurable changes
in BMD. It must be noted, however, that in larger
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anorexic women and adolescents, investigators have
reported both minimal changes and increases in BMD
with weight gain [40,41], highlighting the need for more
research in this area.
Strengths of this case report include the detailed as-
sessments of energy status, the metabolic environment,
menstrual function, and bone health for a 12-month
period. Furthermore, characterizing changes and im-
provements in menstrual function using urinary meta-
bolites of reproductive hormones collected daily for
12 months provides the opportunity to examine subtle
changes in menstrual function that coincide with im-
provements in the energetic and metabolic environ-
ments. A limitation of this case report is the omission of
non-exercise activity thermogenesis from the calculation
of TEE as a result of problems encountered with the ac-
celerometers used for the study, therefore resulting in a
lack of reliable data for this variable.
Conclusion
This case report provides further support for the role of
energy deficiency in menstrual dysfunction among exer-
cising women and the benefits of an adequate energy in-
take on reproductive health. Resumption of menses
coincided closely with weight gain and improvements in
energy status that were achieved by increases in caloric
intake. This case report also demonstrates that the na-
ture of recovery of menstrual function among exercising
women with FHA may differ according to individual dif-
ferences in duration of amenorrhea, body composition,
exercise volume, and the metabolic milieu. Therefore,
the response to an increase in caloric intake as well as
the time course of menstrual recovery is unique to each
woman; however, it appears that improvements in en-
ergy status are closely linked to improvements in men-
strual function. Further research is needed in larger
samples to determine the primary contributors to re-
sumption of menses in amenorrheic, exercising women.
Consent
The participants signed a consent approved by the Institu-
tional Review Board of the Pennsylvania State University
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which informed the participants that the data would be
published in medical journals without personally identifi-
able information. A copy of the signed informed consent
is available for review upon request.
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